Specify a stock or a cryptocurrency in the search bar to get a summary
Forte Biosciences Inc
FBRXForte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Address: 3060 Pegasus Park Drive, Dallas, TX, United States, 75247
Analytics
WallStreet Target Price
150 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures FBRX
Dividend Analytics FBRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FBRX
Stock Valuation FBRX
Financials FBRX
Results | 2019 | Dynamics |